Business Wire

ICSA-BOARDROOM-APPS

Del
BoardPad achieves growth milestone, reaching over 500 clients in the EMEA region

ICSA Boardroom Apps announced its continued growth, surpassing 500 clients across Europe, the Middle East and Africa (EMEA) all using BoardPad , the industry-leading paperless meeting and document collaboration solution to securely distribute board and meeting documents.

This milestone comes off the back of a number of significant investments in the EMEA region, including the opening of a new office in Frankfurt, Germany. The office launch was a result of a strong customer base already established in that region and the location being strategically key to BoardPad’s on-going commitment to clients and additional exciting business opportunities.

As part of BoardPad’s growth strategy, the latest product update for iPads now supports nine languages (English, French, German, Spanish, Greek, Portuguese, Russian, Simplified Chinese and Japanese.). This development is a response to the continuous global growth.

One of BoardPad’s key clients is FTSE 100 company, the London Metal Exchange (LME), the world centre for industrial metals trading and price-risk management. Marcos Castro, Company Secretary at LME comments: “We evaluated various solutions, but BoardPad was, by far, the easiest to use. We felt at ease with the compelling security features and the fact that BoardPad was developed by the software company of the Institute (ICSA), which has an in-depth understanding of the workings of a secretariat function. We did our own penetration testing and we were more than satisfied that BoardPad met all of our security standards.” As a result, BoardPad has also been implemented by its Hong Kong division.

Mike Evans, CEO of ICSA Boardroom Apps comments:

"From the smallest charities to the largest listed companies in Europe, a large amount of organisations are making the transition from traditional paper-based board packs, to using BoardPad’s industry-leading secure, digital board solution. Our blueprint of European clients, particularly in the banking and financial sector, demonstrates our strong position when it comes to addressing complex client needs. With ICSA’s heritage and our hand-holding approach towards clients, we are the provider of choice to deliver good governance to boardrooms across Europe.”

For BoardPad enquiries, please call +44 (0) 20 7497 5511 or email info@boardpad.com .

- End -

About ICSA Boardroom Apps:

ICSA Boardroom Apps is a software company of The ICSA (the Institute of Chartered Secretaries and Administrators), and a sister company of ICSA Software. BoardPad enables secure meeting and document collaboration through an innovative combination of governance expertise and latest, user-friendly technology. Thousands of users in over 140 countries trust BoardPad to securely access and annotate their meeting papers.

BoardPad offers all of the functionalities required to support flexible and efficient board communication from a single secure application, accessed on or offline on an iPad or Windows devices. BoardPad supports English, French, German, Greek, Japanese, Portuguese, Russian, Simplified Chinese, and Spanish and is available as a hosted or on-premise solution.

Contact:

Media contact:
Lakshna Rathod, EMEA Marketing Manager
pr@boardpad.com
+44-(0)20-7497-5511

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release

Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i

The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release

Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP

Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release

New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye